Interesting, but unfortunately, the study did not compare it with other treatments, just placebo. Looks like around a 50% response rate, which is OK. What I find amusing is that placebo has a 25% response rate.
There is one member here who has been taking it, Pkitty, who was unable to get into full remission and went to Cleveland Clinic for a j-pouch, only to be diagnosed with Crohn's. So, she's in a holding pattern right now. I guess the Crohn's diagnosis makes sense now, knowing that vedolizumab works better in UC than Crohn's.
It will be interesting to see how this stacks up against the other biologics. I like the fact that it targets the intestine only. Too bad it is by IV infusion only, or it would be perfect!
The (reported) world IBD incidence of 4 million may be about right, since the U.S. incidence is about 1.4 million. Reporting in less developed countries is not very good.
Jan